Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025
Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025
- US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to January 31, 2025.
- Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of.
- Scilex's transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to January 31, 2025.
- 德克薩斯州南部的美國破產法院發佈了一項命令，將Scilex分紅股票的鎖定期延長至2025年1月31日，該股票前由Sorrento分配。
- 因此，任何Scilex分紅股票的股份（包括券商持有的股份）均不得出售、轉讓或以其他方式處置。
- Scilex的轉讓代理機構，大陸股份轉讓與信託公司，已經被告知將鎖定期延長至2025年1月31日。
PALO ALTO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the U.S. Bankruptcy Court for the Southern District of Texas (the "Court") has extended the expiration of the restrictions on transfer of the shares of common stock of Scilex that were previously distributed by Sorrento Therapeutics, Inc. (OTC:SRNEQ, "Sorrento"))))), Scilex's former controlling stockholder, to Sorrento's stockholders as a dividend on January 19, 2023 (the "Dividend Stock"). Such lock-up period was previously set to expire on the earlier of (i) September 30, 2024 or (ii) the date on which Sorrento and its Official Committee of Unsecured Creditors agreed in writing or on the record in Sorrento's chapter 11 cases certain claims that may be asserted in potential litigation to avoid Sorrento's distribution of Dividend Stock and to recover such Dividend Stock, should not be pursued, or on such date that the Court deems just and proper. On September 25, 2024, the Court approved a motion to extend the lock-up period on the Dividend Stock to January 31, 2025.
加利福尼亞州帕洛阿爾託，2024年9月26日（環球新聞社）--Scilex控股公司（納斯達克股票代碼：SCLX，"Scilex"）是一家專注於收購、開發和商業化非阿片類疼痛管理產品的創新營業收入公司，用於治療急性和慢性疼痛，今日宣佈，美國德克薩斯州南部破產法院（"法院"）已將擴展Scilex普通股轉讓限制的有效期延長至解除股票分紅的限制。Scilex之前由Sorrento Therapeutics, Inc.（場外交易：SRNEQ，"Sorrento"）作爲Scilex前控股股東向Sorrento的股東於2023年1月19日分發的普通股的分紅（"分紅股票"），此類鎖定期之前被設定爲在2024年9月30日或Sorrento及其無抵押債權人官方委員會在Sorrento第11章破產案件中書面同意或記錄的早於的日期結束，以避免Sorrento分配分紅股票的潛在訴訟索賠，並收回該股票，或法院認爲適當的日期結束。 2024年9月25日，法院批准了延長分紅股票鎖定期至2025年1月31日的動議。
譯文內容由第三人軟體翻譯。